source
- FDA issues warning letters to drug makers over CGMP lapses and highlights patient rep ties to industry-backed groupsThe FDA has issued warning letters to several drug manufacturers for failing to meet current good manufacturing practice requirements, citing problems with ensuring product sterility and meeting sp…
- FDA issues warning to Eurofins over selective microbiology data recording at Pennsylvania labFDA sent a warning letter to Eurofins after inspectors found issues at its Horsham, Pennsylvania laboratory. The inspection revealed that analysts had been selectively recording results of pour-pl…BioSpace · 5d agoRegulatoryNegative